Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol
; 83(5): 1282-1293, 2020 Nov.
Article
en En
| MEDLINE
| ID: mdl-32574587
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Corticoesteroides
/
Dermatitis Atópica
/
Anticuerpos Monoclonales Humanizados
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Child
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2020
Tipo del documento:
Article